Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

New on Charts:

We've added Splits, Dividends, Earnings, and Earnings Estimates! Click on individual events to unveil more details.

If you prefer a cleaner view, easily disable them in Settings.

ATHX | Athersys Inc

Index- P/E- EPS (ttm)-3.03 Insider Own2.71% Shs Outstand22.50M Perf Week31.81%
Market Cap9.85M Forward P/E- EPS next Y-0.75 Insider Trans0.00% Shs Float21.89M Perf Month-6.89%
Income-47.41M PEG- EPS next Q-0.21 Inst Own19.35% Short Float / Ratio3.62% / 1.92 Perf Quarter-52.41%
Sales0.15M P/S65.64 EPS this Y82.70% Inst Trans20.68% Short Interest0.79M Perf Half Y-57.92%
Book/sh-1.71 P/B- EPS next Y28.57% ROA-207.55% Target Price5.50 Perf Year-76.35%
Cash/sh0.08 P/C5.47 EPS next 5Y- ROE-1276.02% 52W Range0.26 - 2.76 Perf YTD-47.90%
Dividend- P/FCF- EPS past 5Y-84.03% ROI- 52W High-84.14% Beta-0.75
Dividend %- Quick Ratio0.09 Sales past 5Y136.67% Gross Margin-2.74% 52W Low70.94% ATR0.06
Employees24 Current Ratio0.09 Sales Q/Q-97.88% Oper. Margin-34380.14% RSI (14)55.68 Volatility14.17% 15.33%
OptionableYes Debt/Eq- EPS Q/Q72.58% Profit Margin-32469.18% Rel Volume0.89 Prev Close0.42
ShortableYes LT Debt/Eq- EarningsAug 16 AMC Payout- Avg Volume412.73K Price0.44
Recom1.00 SMA2016.23% SMA50-5.49% SMA200-53.58% Volume368,521 Change3.94%
Date Action Analyst Rating Change Price Target Change
Nov-19-21Downgrade BofA Securities Buy → Neutral
Jun-25-20Initiated BofA/Merrill Buy $5
Aug-26-19Initiated Dawson James Buy $11
Feb-13-18Reiterated Maxim Group Buy $12 → $6
Aug-10-17Reiterated Maxim Group Buy $9 → $12
Feb-07-17Initiated Needham Buy $7
Mar-11-16Reiterated Maxim Group Buy $5 → $10
Jul-09-15Downgrade Piper Jaffray Overweight → Neutral
Jan-23-15Reiterated Maxim Group Buy $7 → $9
Apr-28-14Reiterated Maxim Group Buy $10 → $7
Today 04:30PM
Oct-02-23 05:04PM
Sep-06-23 02:45PM
Aug-25-23 11:36AM
Aug-17-23 09:30PM
05:01PM Loading…
Aug-16-23 05:01PM
Aug-15-23 04:51PM
Aug-11-23 08:00AM
Aug-10-23 12:42PM
Jul-31-23 01:38PM
Jun-01-23 04:40PM
May-23-23 08:30AM
May-18-23 09:58AM
May-08-23 09:49AM
May-01-23 08:30AM
02:23PM Loading…
Apr-21-23 02:23PM
Apr-19-23 04:01PM
Apr-18-23 08:00AM
Apr-10-23 03:29PM
Mar-31-23 06:26PM
Mar-22-23 08:30AM
Feb-28-23 08:15AM
Feb-14-23 03:40PM
Feb-02-23 08:30AM
Jan-30-23 11:20AM
Jan-11-23 07:15PM
Jan-10-23 11:59AM
Jan-09-23 08:30AM
03:25PM Loading…
Jan-06-23 03:25PM
Jan-05-23 04:33PM
Dec-28-22 09:59AM
Nov-15-22 03:44PM
Nov-11-22 08:30AM
Nov-10-22 03:12PM
Nov-09-22 11:58AM
Nov-07-22 06:30PM
Oct-25-22 08:30AM
Oct-04-22 09:25AM
Sep-30-22 12:33PM
Sep-23-22 02:34PM
Sep-19-22 07:00AM
Aug-29-22 06:02PM
Aug-25-22 06:43PM
Aug-17-22 04:30PM
Aug-15-22 12:16PM
Aug-14-22 08:13AM
Aug-11-22 10:30PM
Aug-08-22 11:15AM
Aug-04-22 12:03PM
Aug-02-22 03:34PM
Jul-26-22 10:00AM
Jul-08-22 12:14PM
Jul-05-22 08:30AM
Jun-28-22 02:07PM
Jun-21-22 06:00AM
Jun-17-22 02:55PM
Jun-15-22 08:43AM
Jun-09-22 01:02PM
Jun-08-22 02:45PM
Jun-02-22 06:35PM
May-23-22 03:32PM
May-20-22 10:21AM
May-13-22 08:00AM
May-11-22 06:35AM
May-06-22 08:00AM
May-02-22 09:00AM
Apr-29-22 09:00AM
Apr-04-22 03:40PM
Apr-01-22 04:46PM
Mar-28-22 12:19PM
Mar-16-22 06:23PM
Mar-15-22 04:05PM
Mar-10-22 11:50AM
Mar-08-22 10:56AM
Feb-23-22 09:40AM
Feb-18-22 03:21PM
Feb-17-22 04:30PM
Athersys, Inc. is a biotechnology company, which focuses on the field of regenerative medicine. It engages in the discovery and development of therapies designed to extend and enhance the quality of human life. The firm offers MultiStem as its stem cell product which provides biological potency and therapeutic effects for distinct diseases and conditions in the cardiovascular, neurological, inflammatory, and immune disease areas. The company was founded by John J. Harrington and Gil van Bokkelen on October 24, 1995 and is headquartered in Cleveland, OH.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Camardo Daniel A.CEONov 22Buy0.55100,00054,960368,804Nov 22 03:53 PM